Eevia Health receives multiple sales orders for c. KSEK 702 (KEUR 61)

Eevia Health Plc ("Eevia" or "The Company") received several sales orders for extracts totaling KEUR 61 from various European customers.

Several customers placed a total of KEUR 61 in sales orders. The orders came from the distributor in Germany and a customer in Central Europe, in total KEUR 29 for Feno-Myrtillus 36 Organic and Feno-Myrtillus 25 (Bilberry Extract). One Finnish customer placed an order for a contract manufacturing project, KEUR 6.

Furthermore, a French trading partner ordered Feno-Myrtillus 25 (Bilberry Extract), KEUR 26. The trading partner is known for delivering high-quality natural products and has repeat business for Eevia’s highly concentrated bilberry extracts. The end customer is a large supplement brand.

Eevia has the products in stock so that they can be delivered immediately without purchasing raw materials, which is positive for operational cash flow. These orders are repeat orders, and Eevia expects further repeat orders in the future from the same customers.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected] or [email protected]                      

Telephone: +358 400 22 5967                         

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.